LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
LEPU BIO-B: Proxy Form for the Annual General Meeting to be held on June 19 2024
LEPU BIO-B: Next Day Disclosure Return
LEPU BIO-B: VOLUNTARY ANNOUNCEMENTTHREE CLINICAL TRIAL RESULTSPRESENTED AT 2024 ASCO ANNUAL MEETING
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
LEPU BIO-B: VOLUNTARY ANNOUNCEMENTUPDATE ON THE LICENSE AGREEMENT WITHASTRAZENECA FOR CMG901
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
LEPU BIO-B: VOLUNTARY ANNOUNCEMENT FAST TRACK DESIGNATION GRANTED BY THE FDA TO MRG004A FOR THE TREATMENT OF PANCREATIC CANCER
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
LEPU BIO-B: ARTICLES OF ASSOCIATION
LEPU BIO-B: List of Directors and their Roles and Functions
LEPU BIO-B: PROXY FORM FOR USE AT THE 2024 SECOND EXTRAORDINARY GENERAL MEETING
LEPU BIO-B: (1) PROPOSED RE-ELECTION OF THE BOARD OF DIRECTORS; (2) RETIREMENT OF CO-CHIEF EXECUTIVE OFFICER AND DIRECTORS; (3) PROPOSED RE-ELECTION OF SUPERVISORS; AND (4) PROPOSED AMENDMENTS OF THE ARTICLES OF ASSOCIATION
LEPU BIO-B: PROXY FORM FOR USE AT THE 2024 FIRST EXTRAORDINARY GENERAL MEETING
LEPU BIO-B: Notification Letter with Request Form to Non-Registered Shareholders
LEPU BIO-B: Notification Letter with Request Form to Registered Shareholders
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
LEPU BIO-B: VOLUNTARY ANNOUNCEMENTCOMPLETION OF PATIENT ENROLLMENT OFPIVOTAL PHASE IIb CLINICAL TRIAL FORMRG003 FOR THE TREATMENT OF R/M NPC
No Data